Bioengineering

Genentech Employees Helping to Meet Needs of Life Sciences Firms

Genentech Inc., a long-time source of executive talent for the biotechnology industry, has become a feeder system for venture firms.
In recent months, several Genentech staffers have departed to take junior partner positions at venture firms such as MPM Capital, Cambridge, Mass., and Patricof & Co. Ventures Inc. and J.P. Morgan Partners, both of New York. Overall, at least 10 Genentech employees have moved on to the venture business since 1999 alone. “My Genentech network is two orders of magnitude of all my other networks put together,” said Michael Powell, who left Genentech himself in 1997 to join Sofinnova Ventures,… Continue reading

Ten Most Innovative Entrepreneurs

Fortune has chosen ten female small-business entrepreneurs to join the annual Fortune Most Powerful Women Summit. The ten women join 400 of the world’s most influential women leaders in business, philanthropy, government, education and the arts for panel discussions, on-stage interviews, and interactive sessions over the course of three days.

Wendi Goldsmith, CEO of Bioengineering Group, a woman-owned science and engineering firm headquartered in Salem, MA, was recognized as one of the ten winners. The program, which debuted at the 2009 Summit, targets entrepreneurial women who are game changers, ground-breakers and innovators in their fields. Hundreds of business owners were… Continue reading

What Artificial Neural Networks Can Do

The potential of achieving a great deal of processing power by wiring together a large number of very simple and somewhat primitive devices has captured the imagination of scientists and engineers for many years. In recent years, the possibility of implementing such systems by means of electro-optical devices and in very large scale integrations has resulted in increased research activities.

Artificial neural networks (ANNs) or simply Neural Networks (NNs) are made of interconnected devices called neurons (also called neurodes, nodes, neural units or merely units). Loosely inspired by the makeup of the nervous system, these interconnected devices look at patterns… Continue reading

Biomedical Engineering and the Implantable Ventricular Defibrillator

Sudden cardiac death, often called a massive heart attack, is the leading cause of death in America. Many of these deaths are caused by cardiac arrest (ventricular fibrillation), a breakdown in the normally well-choreographed electrical activity of the heart. In the United States, approximately 500,000 out-of-hospital episodes of ventricular fibrillation occur each year. About 25% survive. Survival is often attributable to the rapid response of paramedics coupled with a bystander’s use of cardiopulmonary resuscitation (CPR).

Without treatment, fibrillation survivors are almost certain to suffer another episode within a year. Even when treated with drugs, survivors have a one-year mortality rate… Continue reading